openPR Logo
Press release

Malaria Diagnostics Market: Huge Growth Opportunities | Industry Trends | Market Analysis & Global Forecast to 2026

03-30-2020 12:52 PM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Malaria Diagnostics Market

Malaria Diagnostics Market

Malaria Diagnostics Market size was valued at $728,870 thousand in 2018, and is expected to reach $1,085,106 thousand by 2026, registering a CAGR of 5.1% from 2019 to 2026.

Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/285

Malaria is a serious infectious disease, which can be lethal for the host if left untreated. Furthermore, it is transmitted through the bite of infected female Anopheles mosquito. The bite leads to spreading of Plasmodium parasites into the blood, which, in, turn spread to liver cells where they multiply at a fast rate to invade red blood cells. These parasites further grow and mature in red blood cells to form merozoites. These merozoites are responsible for rupturing of red blood cells to invade other red blood cells. This leads to fever, tiredness, vomiting, headaches, impaired consciousness, multiple convulsions, and abnormal bleeding. Hence, tests and procedures to identify the disease are necessary and are known as malaria diagnostics. There are different types of malaria diagnostics such as rapid diagnostic tests, microscopy, and molecular diagnostic tests.

The major factor that contributes to the growth of malaria diagnostics market include rise in prevalence of malaria in developing countries. Furthermore, rise in awareness initiatives by governments and surge in research for new malaria diagnostics are the factors that boost the growth of the market. However, lack of awareness about healthcare in developing countries is the major factor that restricts growth of the malaria diagnostics market. Conversely, growth opportunities exhibited by emerging economies is expected to offer lucrative opportunities during the forecast period.

The malaria diagnostics market is studied on the basis of product type, end user, and region to provide a detailed assessment of the market. On the basis of product type, it is segmented into rapid diagnostic tests, microscopy, and molecular diagnostic tests. By end user, it is bifurcated into hospital, clinics, and diagnostic centers. Region wise, it is analyzed across North America (the U.S., and Canada, and Mexico), Europe (Germany, the UK, and rest of Europe), Asia-Pacific (China, India, and rest of Asia-Pacific), and LAMEA (Africa and rest of LAMEA).

According to product type, rapid diagnostic tests acquired the major share of the malaria diagnostics market in 2018, owing to benefits associated with the use of RDTs in the diagnosis of malaria. For instance, RDTs are inexpensive, simple to operate and read, highly sensitive & specific, stable at high temperatures, and provide results in shorter period of time. Therefore, contribute to the growth of malaria diagnostic tests market. Furthermore, the molecular diagnostic tests segment is expected to grow at the fastest pace during the forecast period, owing to high specificity associated with the use of the test, which can lead to better treatment outcomes. In addition, rise in awareness among people regarding early diagnosis of malaria for better treatment supplements the growing demand for malaria diagnostic tests.

Ask for Discount on Purchase @ https://www.alliedmarketresearch.com/purchase-enquiry/285

By end user, the clinics segment acquired the major share of the malaria diagnostics market, owing to surge in number of clinics worldwide. In addition, diagnostic centers are expected to exhibit the fastest growth rate during the forecast period due to surge in awareness related to early diagnosis of malaria infection for better treatment.
By region, LAMEA accounted for the major malaria diagnostics market share in 2018, and is expected to continue this trend, owing to rapid surge in prevalence of malaria in the region.

Moreover, widespread of the malaria vector, Anopheles gambiae, which is difficult to control, in the region is another major factor that leads to surge in cases of malaria. Furthermore, majority of malarial infections in the region are caused by the most lethal type of malarial parasite called as Plasmodium falciparum. Therefore, there is a need for early diagnosis of malaria infection in this region, which boosts the growth of the market. In addition, malaria infection is endemic to some parts of Africa, which leads to the growth of the market in the region. On the other side, Asia-Pacific is estimated to register the fastest growth during the forecast period, attributed to the increase in awareness regarding the use of malaria diagnostics for early diagnosis of the infection for better treatment. The constantly evolving life science industry drives the growth of the market in developing economies such as India, China, and Malaysia, as the constant development leads to surge in awareness related to the use of malaria diagnosticsdiagnostics.

Key Findings of the Study:
o Rapid diagnostic tests segment occupied approximately half the share of the global malaria diagnostics market in 2018.
o The molecular diagnostic tests segment is anticipated to grow with the highest CAGR throughout the forecast period.
o The hospitals segment accounted for one-thirds share of the market in 2018.
o Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA.

Access full Report @ https://www.alliedmarketresearch.com/malaria-diagnostics-market

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Life Science Market: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Malaria Diagnostics Market: Huge Growth Opportunities | Industry Trends | Market Analysis & Global Forecast to 2026 here

News-ID: 1990202 • Views:

More Releases from Allied Market Research

Narrow Pixel Pitch LED Displays Market Latest Trends and Analysis, Future Growth Study by 2032
Narrow Pixel Pitch LED Displays Market Latest Trends and Analysis, Future Growth …
Allied Market Research published an exclusive report, titled, "Narrow Pixel Pitch LED Displays Market Size, Share, Competitive Landscape and Trend Analysis Report by Type, by Application : Global Opportunity Analysis and Industry Forecast, 2022-2031". The global narrow pixel pitch LED displays market was valued at $1.5 billion in 2021, and is projected to reach $7.1 billion by 2031, growing at a CAGR of 16.7% from 2022 to 2031. Download Research Report Sample
Tire Pressure Monitoring System Market Valuation USD 12.32 billion by 2031
Tire Pressure Monitoring System Market Valuation USD 12.32 billion by 2031
The global 𝐓𝐢𝐫𝐞 𝐏𝐫𝐞𝐬𝐬𝐮𝐫𝐞 𝐌𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠 𝐒𝐲𝐬𝐭𝐞𝐦 𝐌𝐚𝐫𝐤𝐞𝐭 was valued at $5.32 billion in 2021, and is projected to reach $12.32 billion by 2031, growing at a CAGR of 8.6% from 2022 to 2031. Surge in demand for safety features in automobiles, growth in implementation of electronic systems in vehicles, and increase in sales of automobiles to drive the growth of the global tire pressure monitoring system market 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬 𝐍𝐨𝐰:
Analyzing the $106.8 Billion Cancer Monoclonal Antibodies Market with a Projected CAGR of 7% through 2031
Analyzing the $106.8 Billion Cancer Monoclonal Antibodies Market with a Projecte …
The robust growth of the cancer monoclonal antibodies market, valued at $55.6 billion in 2021 and projected to soar to $106.8 billion by 2031, highlights the increasing reliance on targeted therapies in oncology. Growing at a compound annual growth rate (CAGR) of 7% from 2022 to 2031, this sector represents a vital component of modern medical science, specifically in the treatment and management of cancer. 𝐆𝐞𝐭 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬
"Decoding the $5,979+ Million Gene Synthesis Market: Insights Unveiled in a Comp …
In recent years, the gene synthesis market has showcased remarkable growth, a trend highlighted in the latest report from Allied Market Research. As of 2021, the market was valued at $1,110 million, with projections estimating a climb to $5,979 million by 2031. This reflects an impressive compound annual growth rate (CAGR) of 18.4% from 2022 to 2031. Such growth underscores the transformative impact of biotechnological advancements and the increasing demand

All 5 Releases


More Releases for Malaria

Industry Dynamics of Cerebral Malaria Therapeutics
Global Cerebral Malaria Therapeutics Market: Overview Cerebral malaria, a severe neuropathological complication, primarily caused by Plasmodium falciparum. The infectious disease has become prevalent in tropical and sub-tropical countries. The cerebral malaria therapeutics market has evolved on the back of increased understanding of pathogenesis of the neurological syndrome. A growing array of biomarkers and tool in recent years have helped underpin the growing revenue potential in the market, giving rise to numerous
Malaria Vaccines – Paving the Way for a Malaria-free World
Recent Study on “Malaria Vaccines Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis and Forecast, 2018-2026” Added to Coherent Market Insights Reports Database. Malaria Vaccines Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Malaria Vaccines market research report is a professional
Malaria Disease Drug Pipeline Analysis
“Malaria Disease Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Malaria. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each drug
Rising Prevalence of Cerebral Malaria and Increasing Novel Drug Treatment Drives …
Malaria is a mosquito-borne infectious disease affecting humans and animals caused by parasitic protozoan belonging to the plasmodium family. Malaria is typically transmitted from human to human through the bite of an infected Anopheles (female) mosquito. Symptoms of malaria include fever, headache, fatigue, muscle pain, diarrhea, anemia, and vomiting. Severe malaria can cause yellow skin, seizures, coma, or death. Cerebral malaria is a form of severe malaria. Cerebral malaria has
03-08-2017 | Health & Medicine
TMR
Rising Prevalence of Cerebral Malaria and Increasing Novel Drug Treatment Drives …
Malaria is a mosquito-borne infectious disease affecting humans and animals caused by parasitic protozoan belonging to the plasmodium family. Malaria is typically transmitted from human to human through the bite of an infected Anopheles (female) mosquito. Symptoms of malaria include fever, headache, fatigue, muscle pain, diarrhea, anemia, and vomiting. Severe malaria can cause yellow skin, seizures, coma, or death. Cerebral malaria is a form of severe malaria. Cerebral malaria has
Malaria Diagnostics Market : Future Growth Potential Of The Malaria Diagnostic & …
Malaria is caused by the Plasmodium parasite, which is transmitted by the female Anopheles mosquito. As per the WHO, there were around 203 mn cases of malaria worldwide in 2012, resulting in approximately 627,000 deaths. The diagnosis of malaria involves detection with the help of blood tests and microscopy. Early and accurate diagnosis of malaria is vital for the rapid recovery of the patient and this has raised investments in